10.3390/jcm12124012 55 DuniA.LiakopoulosV.RapsomanikisK
Nanoscale 6:69456952
Water(Aqua), Glycerin, Acrylates Copolymer, **Niacinamide, Carrageenan, Butylene Glycol, 1,2-Hexanediol, Glucomannan, Hydroxyacetophenone, Cellulose Gum, Calcium Chloride, Ceratonia Siliqua (Carob) Gum, Allantoin, Gardenia Florida Fruit Extract, Polyglyceryl-10 Laurate, Potassium Chloride, Propanediol, Cyamopsis Tetragonoloba (Guar) Gum, Sucrose, Dipotassium Glycyrrhizate, Dextrin, Adenosine, Caprylyl Glycol, Arginine, Ethylhexylglycerin, Panthenol, Sodium Phytate, Sphingomonas Ferment Extract, **Glutathione, Phosphatidylcholine, Squalane, Acetyl Glucosamine, **Arbutin, **Alpha-Arbutin, **Ascorbic Acid, **Kojic Acid, Centella Asiatica Extract, Citrus Limon (Lemon) Fruit Extract, Sodium Hyaluronate, Hydroxypropyltrimonium Hyaluronate, Tocopheryl Acetate, Sodium Acetylated Hyaluronate, Hydrolyzed Hyaluronic Acid, Hyaluronic Acid, Sodium Hyaluronate Crosspolymer, Hydrolyzed Sodium Hyaluronate, Potassium Hyaluronate

Each vial combines GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and KPV (10 mg) 80 mg total allowing researchers to evaluate complementary pathways in controlled in-vitro environments rather than preparing four separate vials
GLP-1 receptor agonistsliraglutide, semaglutide, and later tirzepatidewere developed to help patients with type 2 diabetes regulate blood sugar